Evidence map›Paper›PMID 40765083›Full record

ArticleCurrent topics in medicinal chemistry2026

Total Synthesis of Biologically Potent Peptides and their

Ramya Mariswamy, Veeranjaneyulu Avula, Kiran Kumar Burranboina, Nagendra Govindappa

Abstract read
PubMed Publisher
In one paragraph

Article in Current topics in medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ramya MariswamyDepartment of Chemistry, REVA University, Rukmini Knowledge Park, Kattigenahalli, Yelahanka, Bangalore-560064, Karnataka, India.
Veeranjaneyulu AvulaDepartment of Chemistry, REVA University, Rukmini Knowledge Park, Kattigenahalli, Yelahanka, Bangalore-560064, Karnataka, India.
Kiran Kumar BurranboinaDepartment of Biotechnology, Maharani Lakshmi Ammanni College for Women (mLAC), 18th Cross Road, Malleshwaram Bengaluru, Karnataka-560012, India.
Nagendra GovindappaDepartment of Chemistry, REVA University, Rukmini Knowledge Park, Kattigenahalli, Yelahanka, Bangalore-560064, Karnataka, India.ORCID 0000-0002-5099-3384

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCurrent trends in peptide synthesis protocols have emerged as the most attractive domain in the field of pharma and medicine. Since most of the peptide/peptidomimeticbased molecules serve as potential candidates for many diseases, as they are bioavailable molecules.

methodsWe present the synthesis of bioactive peptides through TAGGING approach with the help of TAG-OH as a linker to the N

resultsFRDEHKK and NKDRG are two peptides that possess antioxidant and antiproliferative activity, and their in-silico investigations reveal that they exhibit anticancer properties when bound to the AXL kinase and EGFR proteins. DISCUSSION: This TAG method enables the easy isolation of peptides at each step as solids, and all the impurities were washed off by simple filtration. The method allows a bulk-scale preparation of the peptides without any difficulty, and hence the protocol is highly efficient for the production of peptides of therapeutic importance.

conclusionThe two peptides FRDEHKK and NKDRG were isolated as fine solids with 82% and 85% yield and were characterized by NMR and MASS spectroscopy. In-silico studies reveal FRDEHKK and NKDRG peptides exhibit good affinity towards EGFR and AXL kinase.

Indexed as

Antineoplastic AgentsAntioxidantsPeptidesAxl Receptor Tyrosine KinaseCell ProliferationComputer SimulationErbB ReceptorsHumansProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesAntineoplastic AgentsAntioxidantsAxl Receptor Tyrosine KinaseErbB ReceptorsPeptidesProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesAnticancerAntioxidantBioactive peptidesFRDEHKKNKDRG peptideTAGGING technique

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.